Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor. (scientific article published on 21 September 2016)

Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts

Q28535054

Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium.

Q34119384

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

Q35087810

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging

Q35227508

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma

Q35483867

The significance of cancer cell expression of the chemokine receptor CXCR4.

Q35832343

[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience

Q36962582

Matching chelators to radiometals for radiopharmaceuticals

Q38156660

Positron emission tomographic imaging of CXCR4 in cancer: challenges and promises.

Q38262289

The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity

Q38876206

PET imaging of CXCR4 receptors in cancer by a new optimized ligand

Q39502623

PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference

Q39523102

Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core

Q39919182

First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography

Q40550081

Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor

Q41385169

Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer

Q41582278

A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography.

Q42167262

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.

Q42545669

First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.

Q52985671

Molecular Imaging of Chemokine Receptor CXCR4 in Non-Small Cell Lung Cancer Using 68Ga-Pentixafor PET/CT: Comparison With 18F-FDG.

Q52985763

[(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction.

Q52986280

Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI.

Q52986842

Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction.

Q52988407

PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.

Q53193739

Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma

Q83082910

First 18F-Labeled Pentixafor-Based Imaging Agent for PET Imaging of CXCR4 Expression In Vivo

Q90455798

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

page(s)

publication date

2016-09-21

P1433

published in

EJNMMI Research

Q27723773

P1476

title

Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor

P478

volume

Reverse relations

cites work (P2860)

Q58783862	CXCR4-directed theranostics in oncology and inflammation
Q89146363	Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models
Q39429246	Theranostic and nanotheranostic probes in nuclear medicine